Jon Cuthbert

Crypto firms and banks failed to reach a compromise on stablecoin yields at a White House meeting as negotiations continue over a Senate bill to regulate US crypto market structure.

Ryman Healthcare (ASX:RYM), the trans-Tasman leader in retirement living, announced a sweeping strategic overhaul and a new capital management framework aimed at unlocking value from its $12 billion portfolio.

The Federal Court of Australia has approved the acquisition of RPMGlobal (ASX:RUL) by Caterpillar through its subsidiary, Revolution HoldCo.

NRW Holdings (ASX:NWH) has kicked off 2026 with a significant expansion of its order book, securing three major civil infrastructure contracts across Western Australia.

Debt ledger specialist Credit Corp (ASX:CCP) reaffirmed its FY26 outlook, projecting a net profit growth of 6% to 17% following a steady first-half performance.

Sagimet Biosciences (NASDAQ:SGMT) announced Monday that its China-based partner, Ascletis Pharma, reported positive topline results from a Phase 3 open-label safety study of denifanstat (ASC40) in patients with moderate to severe acne.

Equinor (NYSE:EQNR) has agreed to divest its entire onshore portfolio in Argentina’s prolific Vaca Muerta shale basin to Vista Energy (NYSE:VIST) in a transaction valued at approximately $1.1 billion.

TuHURA Biosciences (NASDAQ:HURA) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead immune-priming candidate, IFx-2.0, for the treatment of stage IIB to stage IV cutaneous melanoma.

Alliance Resource Partners (NASDAQ:ARLP) reported a massive surge in fourth-quarter profitability on Monday, as record oil and gas royalty volumes and improved coal operational efficiency drove a triple-digit increase in net income.

Dublin-based Aptiv (NYSE:APTV), a global technology company focused on enabling a more automated, electrified, and digitalized future, today reported record financial results for the fourth quarter and full year ended December 31, 2025.